Asthma Devices Market Research Report – Global Forecast till 2027

Asthma Device Market Research Report: By Type (Inhalers, Nebulizers, Dry Powder Inhalers, Metered-Dose Inhalers, Mesh Nebulizers) By Technology (Manually Operated, Digitally Operated) By End Users (Hospital, Retail Pharmacies) – Global Forecast till 2027

ID: MRFR/MED/1093-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill Sample form for the updated data.

Market Scenario:


Asthma is a chronic inflammatory lung disease that narrows the airways. Asthma causes recurring periods of wheezing, chest tightness, shortness of breath, and coughing. Mostly, the symptoms associated with asthma are short-lived and can be easily treated. Asthma inhalers are medical devices which deliver medication into the body via the lungs, thereby, treating asthma and chronic obstructive pulmonary disease. Increasing prevalence of asthma is one of the major drivers for the market growth. According to the World Health Organization in 2017, approximately 235 million people suffered from asthma. Moreover, it was estimated that in 2015, the disease killed approximately 383 million patients around the globe. Additionally, rising healthcare expenditures and increasing awareness fuel the market growth. However, long treatment procedures and low per capita income followed by lack of favorable reimbursement policies in the developing countries will restrain the market growth during the forecast period. 

The global asthma devices market is expected to grow at an approximate CAGR of 4.3% during the forecast period. 


Intended Audience



  • Pharmaceutical Companies

  • Biotechnological Institutes

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers 


Figure 1:- Global asthma devices market share, by region
Global asthma devices market
Sources: WHO, annual reports, press release, white paper, and company presentation


Segmentation


The global asthma devices market is segmented on the basis of type, technology, and end users.


On the basis of the type, the market is segmented into inhalers, nebulizers, and others. The inhalers segment is sub-segmented into metered-dose inhalers and dry powder inhalers. The metered-dose inhalers segment, by inhalers, is further categorized into standard pressurized metered-dose inhalers, breath-activated pressurized metered-dose inhalers, metered-dose inhalers with a spacer, and others. The nebulizers segment is sub-segmented into compressor nebulizers, ultrasonic nebulizers, mesh nebulizers, and others.


On the basis of technology, the market is segmented into manually operated inhaler devices, digitally operated inhaler devices, and others.


On the basis of end users, the market is segmented into hospital, clinics, retail pharmacies, and others.


Regional Analysis 


The Americas dominate the global asthma devices market owing to a well-developed healthcare sector and huge patient population for asthma diseases. According to the Centres for Disease Control and Prevention, in 2015, approximately, 7.8% of the total population in the U.S. was identified for the presence of asthma. Moreover, changing lifestyle and increasing healthcare expenditure fuels the market growth. Additionally, the presence of global players like Merck & Co., Inc. and Baxter, and others boost market growth during the forecast period. 

Europe is the second largest asthma devices market owing to a well-developed healthcare infrastructure and huge patient population. Moreover, government support for research & development and rising healthcare expenditures fuel the market growth. According to a study published in the Asthma Research and Practice journal in 2017, the yearly estimated cost for all the asthmatics per patient is about USD 1,900. Additionally, the presence of the developed economies like the U.K, Germany, and France within the region boosts the market growth. 

Asia Pacific is the fastest growing region in the global market due to the presence of a huge patient population and continuously developing economies like India and China. According to a study of the Indian Chest Society in 2015, 300 million people suffered from asthma worldwide and about a tenth of its share is in India. Moreover, as per the Indian Brand Equity Foundation in 2017, the Indian healthcare sector is one of the fastest growing industries and is expected to advance at a CAGR of 22.8% and reach USD 280 billion by 2020. Moreover, favorable government policies like reduced excise and customs duty followed by the exemptions in service tax along boosts the market growth. 

On the other hand, the Middle East & Africa holds the least share of the global asthma devices market due to the presence of poor economy, especially within the African region. The absence of the developed healthcare sector and stringent government policies restrain the market growth within the African region. Majority of the market within the region is held by the Middle East due to huge healthcare expenditures. 

Research Methodology


Asthma Devices Market
Sources: WHO, annual reports, press release, white paper, and company presentation 


Key players for global asthma devices market


GlaxoSmithKline plc. (Europe), Merck & Co., Inc. (U.S.), 3M (U.S.), Aristopharma Ltd. (Asia Pacific), SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific), AstraZeneca (Europe), Baxter. (U.S.), Boehringer Ingelheim GmbH (Europe), Koninklijke Philips N.V. (Europe), and others.



TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Asthma Devices Market, by Type

6.1 Introduction

6.2 Inhalers

Market Estimates & Forecast, 2020-2027

6.2.1 Metered-Dose Inhalers

6.2.1.1 Standard Pressurized Metered-Dose Inhalers

6.2.1.2 Breath-Activated Pressurized Metered-Dose Inhalers

6.2.1.3 Metered-Dose Inhalers with a Spacer

6.2.2 Dry Powder Inhalers

6.2.3 Others

6.3 Nebulizers Market Estimates & Forecast, 2020-2027

6.3.1 Compressor Nebulizers

6.3.2 Ultrasonic Nebulizers

6.3.3 Mesh Nebulizers

6.3.4 Others

6.4 Others

Chapter 7. Global Asthma Devices Market, by Technology

7.1 Introduction

7.2 Manually Operated Inhaler Devices Market Estimates & Forecast, 2020-2027

7.3 Digitally Operated Inhaler Devices Market Estimates & Forecast, 2020-2027

7.4 Others

Chapter 8. Global Asthma Devices Market, by End Users

8.1 Introduction

8.2 Hospitals & Clinics Market Estimates & Forecast, 2020-2027

8.3 Retail Pharmacies Market Estimates & Forecast, 2020-2027

8.4 Home Care Market Estimates & Forecast, 2020-2027

8.5 Others

Chapter 9. Global Asthma Devices Market, by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 GlaxoSmithKline plc.

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Merck & Co., Inc.

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 3M

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Aristopharma Ltd.

11.4.1 Company Overview

11.4.2 Type/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 SRS PHARMACEUTICALS PVT. LTD.

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 AstraZeneca

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Baxter

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Boehringer Ingelheim GmbH

11.8.1 Overview

11.8.2 Type Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Koninklijke Philips N.V.

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Global Asthma Devices Market

Chapter 13 Appendix

LIST OF TABLES

Table 1 Global Asthma Devices Industry Synopsis, 2020-2027

Table 2 Global Asthma Devices Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Asthma Devices Market by Region, 2020-2027, (USD Million)

Table 4 Global Asthma Devices Market by Type, 2020-2027, (USD Million)

Table 5 Global Asthma Devices Market by Technology, 2020-2027, (USD Million)

Table 6 Global Asthma Devices Market by End Users, 2020-2027, (USD Million)

Table 7 North America Global Asthma Devices Market by Type, 2020-2027, (USD Million)

Table 8 North America Global Asthma Devices Market by Technology, 2020-2027, (USD Million)

Table 9 North America Global Asthma Devices Market by End Users, 2020-2027, (USD Million)

Table 10 U.S. Global Asthma Devices Market by Type, 2020-2027, (USD Million)

Table 11 U.S. Global Asthma Devices Market by Technology, 2020-2027, (USD Million)

Table 12 U.S. Global Asthma Devices Market by End Users, 2020-2027, (USD Million)

Table 13 Canada Global Asthma Devices Market by Type, 2020-2027, (USD Million)

Table 14 Canada Global Asthma Devices Market by Technology, 2020-2027, (USD Million)

Table 15 Canada Global Asthma Devices Market by End Users, 2020-2027, (USD Million)

Table 16 South America Global Asthma Devices Market by Type, 2020-2027, (USD Million)

Table 17 South America Global Asthma Devices Market by Technology, 2020-2027, (USD Million)

Table 18 South America Global Asthma Devices Market by End Users, 2020-2027, (USD Million)

Table 19 Europe Global Asthma Devices Market by Type, 2020-2027, (USD Million)

Table 20 Europe Global Asthma Devices Market by Technology, 2020-2027, (USD Million)

Table 21 Europe Global Asthma Devices Market by End Users, 2020-2027, (USD Million)

Table 22 Western Europe Global Asthma Devices Market by Type, 2020-2027, (USD Million)

Table 23 Western Europe Global Asthma Devices Market by Technology, 2020-2027, (USD Million)

Table 24 Western Europe Global Asthma Devices Market by End Users, 2020-2027, (USD Million)

Table 25 Eastern Europe Global Asthma Devices Market by Type, 2020-2027, (USD Million)

Table 26 Eastern Europe Global Asthma Devices Market by Technology, 2020-2027, (USD Million)

Table 27 Eastern Europe Global Asthma Devices Market by End Users, 2020-2027, (USD Million)

Table 28 Asia Pacific Global Asthma Devices Market by Type, 2020-2027, (USD Million)

Table 29 Asia Pacific Global Asthma Devices Market by Technology, 2020-2027, (USD Million)

Table 30 Asia Pacific Global Asthma Devices Market by End Users, 2020-2027, (USD Million)

Table 31 Middle East & Africa Global Asthma Devices Market by Type, 2020-2027, (USD Million)

Table 32 Middle East & Africa Global Asthma Devices Market by Technology, 2020-2027, (USD Million)

Table 33 Middle East & Africa Global Asthma Devices Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Asthma Devices Market

Figure 3 Market Dynamics for Global Asthma Devices Market

Figure 4 Global Asthma Devices Market Share, by Type 2020

Figure 5 Global Asthma Devices Market Share, by Technology 2020

Figure 6 Global Asthma Devices Market Share, by End Users, 2020

Figure 7 Global Asthma Devices Market Share, by Region, 2020

Figure 8 North America Global Asthma Devices Market Share, by Country, 2020

Figure 9 Europe Global Asthma Devices Market Share, by Country, 2020

Figure 10 Asia Pacific Global Asthma Devices Market Share, by Country, 2020

Figure 11 Middle East & Africa Global Asthma Devices Market Share, by Country, 2020

Figure 12 Global Asthma Devices Market: Company Share Analysis, 2020 (%)

Figure 13 GlaxoSmithKline plc.: Key Financials

Figure 14 GlaxoSmithKline plc.: Segmental Revenue

Figure 15 GlaxoSmithKline plc.: Geographical Revenue

Figure 16 Merck & Co., Inc.: Type UK Ltd: Key Financials

Figure 17 Merck & Co., Inc.: Type UK Ltd: Segmental Revenue

Figure 18 Merck & Co., Inc.: Type UK Ltd: Geographical Revenue

Figure 19 3M: Key Financials

Figure 20 3M: Segmental Revenue

Figure 21 3M: Geographical Revenue

Figure 22 Aristopharma Ltd.: Key Financials

Figure 23 Aristopharma Ltd.: Segmental Revenue

Figure 24 Aristopharma Ltd.: Geographical Revenue

Figure 25 SRS PHARMACEUTICALS PVT. LTD.: Key Financials

Figure 26 SRS PHARMACEUTICALS PVT. LTD.: Segmental Revenue

Figure 27 SRS PHARMACEUTICALS PVT. LTD.: Geographical Revenue

Figure 28 AstraZeneca: Key Financials

Figure 29 AstraZeneca: Segmental Revenue

Figure 30 AstraZeneca: Geographical Revenue

Figure 31 Baxter.: Key Financials

Figure 32 Baxter.: Segmental Revenue

Figure 33 Baxter.: Geographical Revenue

Figure 34 Boehringer Ingelheim GmbH: Key Financials

Figure 35 Boehringer Ingelheim GmbH: Segmental Revenue

Figure 36 Boehringer Ingelheim GmbH: Geographical Revenue

Figure 37 Koninklijke Philips N.V.: Key Financials

Figure 38 Koninklijke Philips N.V.: Segmental Revenue

Figure 39 Koninklijke Philips N.V.: Geographical Revenue